Common Contracts

Option and License Agreement

Option and License Agreement • July 28th, 2020 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Option and License Agreement
• Filed
  July 28th, 2020
• Company
  Inhibrx, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Option and License Agreement (this “Agreement”), effective as of June 9, 2020 (the “Effective Date”), is entered into by and between Inhibrx, Inc., a Delaware corporation (“Inhibrx”), and bluebird bio, Inc., a Delaware corporation (“Licensee”). Inhibrx and Licensee are referred to individually as a “Party” and collectively as the “Parties.”

Option and License Agreement

Option and License Agreement • June 26th, 2020 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Option and License Agreement
• Filed
  June 26th, 2020
• Company
  Inhibrx, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Option and License Agreement (this “Agreement”), effective as of June 9, 2020 (the “Effective Date”), is entered into by and between Inhibrx, Inc., a Delaware corporation (“Inhibrx”), and bluebird bio, Inc., a Delaware corporation (“Licensee”). Inhibrx and Licensee are referred to individually as a “Party” and collectively as the “Parties.”